Toupin-April Karine, Barton Jennifer, Fraenkel Liana, Li Linda, Grandpierre Viviane, Guillemin Francis, Rader Tamara, Stacey Dawn, Légaré France, Jull Janet, Petkovic Jennifer, Scholte-Voshaar Marieke, Welch Vivian, Lyddiatt Anne, Hofstetter Cathie, De Wit Maarten, March Lyn, Meade Tanya, Christensen Robin, Gaujoux-Viala Cécile, Suarez-Almazor Maria E, Boonen Annelies, Pohl Christoph, Martin Richard, Tugwell Peter S
From the Children's Hospital of Eastern Ontario Research Institute and Department of Pediatrics, University of Ottawa, Ottawa, Ontario, Canada; VA Portland Health Care System, and Oregon Health and Science University, Portland, Oregon, USA; Department of Internal Medicine, Yale University, New Haven, Connecticut, USA; Department of Physical Therapy, University of British Columbia and Arthritis Research Centre of Canada, Vancouver, British Columbia, Canada; School of Rehabilitation Sciences, University of Ottawa, Ottawa, Ontario, Canada; Rheumatic Diseases, University of Lorraine, Nancy, France; Institute of Population Health, Centre for Global Health, and School of Nursing, University of Ottawa, Ottawa, Ontario, Canada; Department of Family Medicine and Emergency Medicine, Université Laval, Québec City, Québec, Canada; Bruyere Research Institute, University of Ottawa, Ottawa, Ontario, Canada; University of Twente, Enschede; VU Medical Centre, Amsterdam, The Netherlands; Department of Medicine, University of Sydney, Institute of Bone and Joint Research; University of Western Sydney, Sydney, Australia; Musculoskeletal Statistics Unit, The Parker Institute, Department of Rheumatology, University of Copenhagen, Bispebjerg and Frederiksberg Hospitals, Copenhagen, Denmark; Department of Rheumatology, Nîmes University Hospital, Montpellier I University, Nîmes, France; Department of General Internal Medicine, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center and Caphri Research Institute, Maastricht University, Maastricht, The Netherlands; Department of Internal Medicine II Rheumatology, Clinical Immunology, Osteology, Physical Therapy and Sports Medicine, Schlosspark-Klinik, Teaching Hospital of the Charité, University Medicine, Berlin, Germany; Rheumatology, Michigan State University College of Human Medic
J Rheumatol. 2015 Dec;42(12):2442-7. doi: 10.3899/jrheum.141205. Epub 2015 Apr 15.
Despite the importance of shared decision making for delivering patient-centered care in rheumatology, there is no consensus on how to measure its process and outcomes. The aim of this Outcome Measures in Rheumatology (OMERACT) working group is to determine the core set of domains for measuring shared decision making in intervention studies in adults with osteoarthritis (OA), from the perspectives of patients, health professionals, and researchers.
We followed the OMERACT Filter 2.0 method to develop a draft core domain set by (1) forming an OMERACT working group; (2) conducting a review of domains of shared decision making; and (3) obtaining opinions of all those involved using a modified nominal group process held at a session activity at the OMERACT 12 meeting.
In all, 26 people from Europe, North America, and Australia, including 5 patient research partners, participated in the session activity. Participants identified the following domains for measuring shared decision making to be included as part of the draft core set: (1) identifying the decision, (2) exchanging information, (3) clarifying views, (4) deliberating, (5) making the decision, (6) putting the decision into practice, and (7) assessing the effect of the decision. Contextual factors were also suggested.
We proposed a draft core set of shared decision-making domains for OA intervention research studies. Next steps include a workshop at OMERACT 13 to reach consensus on these proposed domains in the wider OMERACT group, as well as to detail subdomains and assess instruments to develop a core outcome measurement set.
尽管共同决策对于在风湿病学中提供以患者为中心的护理至关重要,但对于如何衡量其过程和结果尚无共识。风湿病学疗效指标(OMERACT)工作组的目的是从患者、卫生专业人员和研究人员的角度,确定在成人骨关节炎(OA)干预研究中衡量共同决策的核心领域集。
我们遵循OMERACT Filter 2.0方法来制定核心领域集草案,具体步骤为:(1)组建OMERACT工作组;(2)对共同决策的领域进行综述;(3)在OMERACT 12会议的一次会议活动中,通过改良的名义小组法征求所有相关人员的意见。
共有来自欧洲、北美和澳大利亚的26人参加了此次会议活动,其中包括5名患者研究伙伴。参与者确定了以下作为核心领域集草案一部分的衡量共同决策的领域:(1)确定决策;(2)交流信息;(3)阐明观点;(4)审议;(5)做出决策;(6)将决策付诸实践;(7)评估决策效果。还提出了背景因素。
我们提出了一份用于OA干预研究的共同决策领域核心集草案。下一步包括在OMERACT 13会议上举办一次研讨会,以便在更广泛的OMERACT小组中就这些提议的领域达成共识,同时详细阐述子领域并评估相关工具,以制定一套核心疗效测量指标。